GlassScriptPhysician profile
Lee N Anton
NPI 1942202478
$5,123.25
in general payments reported to CMS, 2019-2025
38 companies · $626 in 2025
The $626 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $42.35 · 2021: $11.76 · 2022: $803 · 2023: $1,767 · 2024: $1,028 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,421.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $817.92 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $521.08 | 2019-2025 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $484.15 | 2019-2025 | Rybelsus, Ozempic |
| Boston Scientific Corporation | $460.89 | 2023-2024 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $336.13 | 2019-2025 | |
| Amgen INC. | $333.45 | 2019-2025 | Repatha, Otezla, Tepezza |
| Glaxosmithkline, LLC. | $323.14 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $215.05 | 2019-2025 | Airsupra, Breztri |
| Merck Sharp & Dohme LLC | $187.02 | 2019-2025 | Capvaxive |
| Corcept Therapeutics | $155.06 | 2023-2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.62 | 2019-2024 | Jardiance, Synjardy |
| E.R. Squibb & Sons, L.L.C. | $133.61 | 2019-2024 | Eliquis, Camzyos |
| Allergan, INC. | $119.97 | 2019 | |
| Xeris Pharmaceuticals, INC. | $104.70 | 2023-2024 | Recorlev, Gvoke Hypopen |
| Abbott Laboratories | $96.46 | 2022-2025 | Freestyle Libre 2, Aveir, Freestyle Libre 3 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Anton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.